Episodes 46-60 of 160
APOL1 and Chronic Kidney Disease: New Findings in African Populations
Clinician's RoundtableAPOL1 and Chronic Kidney Disease: New Findings in African Populations
Diagnosing IgAN: The Importance of Early and Accurate Identification
Clinician's RoundtableDiagnosing IgAN: The Importance of Early and Accurate Identification
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Clinician's RoundtableInvestigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
IgAN Explained: Key Differences from Other Kidney Conditions
Clinician's RoundtableIgAN Explained: Key Differences from Other Kidney Conditions
Measuring IgAN Risk: Genetic, Environmental, and Systemic Factors
Clinician's RoundtableMeasuring IgAN Risk: Genetic, Environmental, and Systemic Factors
Deciphering IgA Nephropathy: Insights into the Diagnostic Process
On the Frontlines of IgA NephropathyDeciphering IgA Nephropathy: Insights into the Diagnostic Process
- advertisement
The Diagnostic Journey of IgA Nephropathy: Identifying Key Obstacles
On the Frontlines of IgA NephropathyThe Diagnostic Journey of IgA Nephropathy: Identifying Key Obstacles
Nutritional Strategies for Managing IgA Nephropathy
Clinician's RoundtableNutritional Strategies for Managing IgA Nephropathy
Rare Kidney Disease: A Parent and Caregiver’s Perspective
Clinician's RoundtableRare Kidney Disease: A Parent and Caregiver’s Perspective
Decoding Proteinuria: A Window into Kidney Health in IgAN
Clinician's RoundtableDecoding Proteinuria: A Window into Kidney Health in IgAN
Unlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
On the Frontlines of IgA NephropathyUnlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
On the Frontlines of IgA NephropathyDiagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
- advertisement
Advances in IgAN: New Frontiers in Biomarkers and Treatment
On the Frontlines of IgA NephropathyAdvances in IgAN: New Frontiers in Biomarkers and Treatment
Reducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
On the Frontlines of IgA NephropathyReducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
Innovations in IgAN Care: Examining the Evolving Treatment Landscape
On the Frontlines of IgA NephropathyInnovations in IgAN Care: Examining the Evolving Treatment Landscape
